2015
DOI: 10.2310/7750.2014.14047
|View full text |Cite
|
Sign up to set email alerts
|

In-Transit Metastasis from Primary Cutaneous Squamous Cell Carcinoma in a Nonimmunosuppressed Patient

Abstract: We present a case of in-transit metastasis in a nonimmunosuppressed patient with a primary cutaneous squamous cell carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…Our patient fulfilled all these diagnostic criteria, although his primary tumor was moderately differentiated while the metastatic disease was poorly differentiated in nature. Other cases have also similarly reported worsening tumor differentiation at the site of the in-transit metastasis compared to the primary tumor [ 3 ].…”
Section: Discussionmentioning
confidence: 99%
“…Our patient fulfilled all these diagnostic criteria, although his primary tumor was moderately differentiated while the metastatic disease was poorly differentiated in nature. Other cases have also similarly reported worsening tumor differentiation at the site of the in-transit metastasis compared to the primary tumor [ 3 ].…”
Section: Discussionmentioning
confidence: 99%
“…Prognosis was poor with 5-year overall survival of 13%. 12 Important to have a low index of suspicion when evaluating new skin lesions in elderly / immunocompromised patients. Subcutaneous SCCs may be a sign of cutaneous or extracutaneous metastasis and are particularly aggressive and recurrent, it is important to treat such cancers aggressively to optimize patient outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…This disease entity was subsequently reported among immunocompetent patients. [13][14][15][16] Within the head and neck region these can occur in either the parotid basin or cervical region. STM is now known to occur in a variety of malignancies including melanoma (in-transit metastases) 17 and mucosal squamous cell carcinoma of the head and neck, 18 however, there is little known about their prognostic significance in head and neck cutaneous squamous cell carcinoma (HNcSCC).…”
Section: Introductionmentioning
confidence: 99%